BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The momentum in anti-HER2 drug development is exploding:\n\nOu
 tcomes for HER2-expressing breast cancer are patients constantly improvin
 g\; diagnostics\, trial design and innovative drug design are at an all-t
 ime high\; complementing the newly accessible HER2 'low' space and wider 
 range of tumor indications\; the last year has given us more progress in 
 HER2-targeted therapies than ever before.\n\nAs such\, the HER2-Targeted 
 Therapies Summit returns for its second year as the only industry-dedicat
 ed forum for large pharma\, biotech and academia to unite under one roof 
 to discuss these developments\, gain competitive insights and ultimately 
 turbocharge practice-changing anti-HER2 drugs to patients.\n\nAs the clin
 ical and commercial opportunity of HER2-targeted therapies becomes appare
 nt\, join us to connect with over 80+ HER2 experts and expand the clinica
 l utility of your pipeline by exploring HER2 as a multi-tumor target.\n\n
 Early bird rates are available!\n
DTEND:20220616T170000
DTSTAMP:20260512T232941Z
DTSTART:20220614T090000
LOCATION:Hyatt Regency Boston\, 1\, Avenue de Lafayette\, Boston\, Suffolk
  County\, 02111\,
SEQUENCE:0
SUMMARY:The momentum in anti-HER2 drug development is exploding:\nOutcomes
  for HER2-expressing breast cancer are patients constantly improving\; di
 agnostics...
UID:a778f344-9265-48c1-a383-94672effe03c
END:VEVENT
END:VCALENDAR